4732 On Other Exchanges
Symbol
Exchange
Taiwan

naturewise biotech & medical (4732) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NATUREWISE BIOTECH & MEDICAL (4732)
\

Related News

No related news articles were found.

naturewise biotech & medical (4732) Related Businessweek News

No Related Businessweek News Found

naturewise biotech & medical (4732) Details

NatureWise Biotech & Medicals Corporation engages in the development of therapeutic drugs in Taiwan. It offers LipoCol Forte, a capsule for hypercholesterolemia and hypertriglyceridemia; and PPL product comprise Taiwanese Green Propolis. The company also provides dietary supplement products. Its products under development include NBM-BMX, an isoform- selective histone daecetylase 8 inhibitor for oncology and alzheimer disease; and NBM-I001 for retinopathy disease. The company was founded in 2000 and is based in Taipei City, Taiwan.

Founded in 2000

naturewise biotech & medical (4732) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

naturewise biotech & medical
Naturewise Biotech & Medicals Corporation Reports Earnings Results for the Full Year Ended December 31, 2018

NatureWise Biotech & Medicals Corporation announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was TWD 108.479 million compared to TWD 69.103 million a year ago. Operating loss was TWD 21.778 million compared to TWD 59.951 million a year ago. Net loss was TWD 14.815 million compared to TWD 60.494 million a year ago. Basic loss per share was TWD 0.42 compared to TWD 1.73 a year ago.

NatureWise Biotech & Medicals Corporation, Annual General Meeting, Jun 08, 2018

NatureWise Biotech & Medicals Corporation, Annual General Meeting, Jun 08, 2018.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

4732 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4732.
View Industry Companies
 

Industry Analysis

4732

Industry Average

Valuation 4732 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.1x
Price/Book 2.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NATUREWISE BIOTECH & MEDICAL, please visit www.naturewise.com.tw. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.